'Big data' in pharmaceutical science
- Author(s)
- Al G Dossetter, Gerhard Ecker, Hugh Laverty, John Overington
- Abstract
Future Medicinal Chemistry invited a selection of experts to express their views on the current impact of big data in drug discovery and design, as well as speculate on future developments in the field. The topics discussed include the challenges of implementing big data technologies, maintaining the quality and privacy of data sets, and how the industry will need to adapt to welcome the big data era. Their enlightening responses provide a snapshot of the many and varied contributions being made by big data to the advancement of pharmaceutical science.
- Organisation(s)
- External organisation(s)
- Unknown External Organisation Unbekannt/undefiniert
- Journal
- Future Medicinal Chemistry
- Volume
- 6
- Pages
- 857-864
- No. of pages
- 8
- ISSN
- 1756-8919
- DOI
- https://doi.org/10.4155/fmc.14.45
- Publication date
- 05-2014
- Peer reviewed
- Yes
- Austrian Fields of Science 2012
- 301207 Pharmaceutical chemistry, 102020 Medical informatics
- Portal url
- https://ucrisportal.univie.ac.at/en/publications/3ae2ea45-502e-4e2b-8a99-0373f89f92a1